ERIS Lifesciences Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Tata Teleservices (Maharashtra) Ltd, Anand Rathi Wealth Ltd, Triveni Engineering and Industries Ltd, L T Foods Ltd are among the other stocks to see a surge in volumes on NSE today, 09 December 2025.

ERIS Lifesciences Ltd notched up volume of 23.3 lakh shares by 14:14 IST on NSE, a 42.02 fold spurt over two-week average daily volume of 55442 shares. The stock rose 7.65% to Rs.1,651.20. Volumes stood at 37264 shares in the last session.

Tata Teleservices (Maharashtra) Ltd recorded volume of 818.64 lakh shares by 14:14 IST on NSE, a 34.1 times surge over two-week average daily volume of 24.01 lakh shares. The stock gained 16.34% to Rs.53.11. Volumes stood at 64.47 lakh shares in the last session.

Anand Rathi Wealth Ltd saw volume of 27.3 lakh shares by 14:14 IST on NSE, a 31.11 fold spurt over two-week average daily volume of 87765 shares. The stock increased 0.11% to Rs.2,842.50. Volumes stood at 2.83 lakh shares in the last session.

Triveni Engineering and Industries Ltd recorded volume of 43.42 lakh shares by 14:14 IST on NSE, a 24.76 times surge over two-week average daily volume of 1.75 lakh shares. The stock gained 7.29% to Rs.362.65. Volumes stood at 2.15 lakh shares in the last session.

L T Foods Ltd registered volume of 33.62 lakh shares by 14:14 IST on NSE, a 8.81 fold spurt over two-week average daily volume of 3.82 lakh shares. The stock slipped 2.15% to Rs.385.05. Volumes stood at 5.02 lakh shares in the last session.

Powered by Capital Market - Live News

The board of ERIS Lifesciences at its meeting held on 24 November 2025 has approved the acquisition of balance 30% of the total share capital of Swiss Parenterals, a subsidiary of the Company.

Further, the board has approved the issuance of up to 23,06,372 equity shares of the Company on preferential basis to discharge the consideration for acquisition of 30% stake in Swiss Parenterals.

Powered by Capital Market - Live News

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 24 November 2025.

Powered by Capital Market - Live News

Net profit of ERIS Lifesciences rose 31.23% to Rs 120.19 crore in the quarter ended September 2025 as against Rs 91.59 crore during the previous quarter ended September 2024. Sales rose 6.93% to Rs 790.15 crore in the quarter ended September 2025 as against Rs 738.95 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News